$HZNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Horizon Therapeutics Public Ltd Co. Get notifications about new insider transactions in Horizon Therapeutics Public Ltd Co for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | A | 12.94 | 42,295 | 547,297 | 42,295 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | A | 5.20 | 47,654 | 247,801 | 47,654 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | A | 10.43 | 46,335 | 483,274 | 46,335 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Grant | A | 0.00 | 94,290 | 0 | 94,290 | 0 to 94.3 K |
Sep 22 2014 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 0.00 | 23,622 | 0 | 23,622 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 12.70 | 33,286 | 422,732 | 33,286 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 0.00 | 124,100 | 0 | 124,100 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 13.34 | 140,000 | 1,867,600 | 140,000 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 13.34 | 100,000 | 1,334,000 | 100,000 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 4.31 | 6,913 | 29,781 | 6,913 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Grant | A | 0.00 | 57,655 | 0 | 57,655 | 0 to 57.7 K |
Sep 22 2014 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | D | 15.96 | 20,000 | 319,200 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | D | 12.29 | 40,000 | 491,600 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 0.00 | 198,000 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 7.61 | 223,000 | 1,697,030 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 0.00 | 96,525 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 2.40 | 147,000 | 352,800 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 0.00 | 66,421 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 4.96 | 216,955 | 1,076,097 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 12.94 | 112,787 | 1,459,464 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 5.20 | 128,937 | 670,472 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | D | 10.43 | 121,701 | 1,269,341 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Sell | D | 0.00 | 164,060 | 0 | 0 | 164.1 K to 0 (-100.00 %) |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Option Exercise | D | 0.00 | 62,000 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Option Exercise | D | 7.61 | 70,000 | 532,700 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Option Exercise | D | 0.00 | 41,250 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Option Exercise | D | 2.40 | 61,000 | 146,400 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Option Exercise | D | 0.00 | 6,699 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Option Exercise | D | 4.96 | 21,880 | 108,525 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Option Exercise | D | 20.78 | 18,955 | 393,885 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP, Chief Commerci ... | Sell | D | 0.00 | 54,138 | 0 | 0 | 54.1 K to 0 (-100.00 %) |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 0.00 | 62,000 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 7.61 | 70,000 | 532,700 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 0.00 | 33,750 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 2.40 | 51,000 | 122,400 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 0.00 | 16,416 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 4.96 | 53,621 | 265,960 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 12.94 | 42,295 | 547,297 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 5.20 | 47,654 | 247,801 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Option Exercise | D | 13.47 | 46,335 | 624,132 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP, Chief Medical ... | Sell | D | 0.00 | 99,298 | 0 | 0 | 99.3 K to 0 (-100.00 %) |
Sep 22 2014 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | D | 7.48 | 10,530 | 78,764 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | D | 15.96 | 20,000 | 319,200 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | D | 2.37 | 20,000 | 47,400 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | D | 3.95 | 5,265 | 20,797 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, Finance | Option Exercise | D | 0.00 | 80,000 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, Finance | Option Exercise | D | 15.96 | 90,000 | 1,436,400 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | D | 4.31 | 690,369 | 2,974,110 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Sell | D | 0.00 | 5,064,827 | 0 | 0 | 5.1 M to 0 (-100.00 %) |
Sep 22 2014 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | D | 7.48 | 10,530 | 78,764 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | D | 15.96 | 20,000 | 319,200 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | D | 2.37 | 20,000 | 47,400 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | D | 3.95 | 5,265 | 20,797 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 0.00 | 62,000 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 7.61 | 70,000 | 532,700 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 0.00 | 33,750 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 2.40 | 51,000 | 122,400 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 0.00 | 16,416 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 4.96 | 53,621 | 265,960 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 12.94 | 42,295 | 547,297 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 5.20 | 47,654 | 247,801 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Option Exercise | D | 10.43 | 46,335 | 483,274 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP and CFO | Sell | D | 0.00 | 94,290 | 0 | 0 | 94.3 K to 0 (-100.00 %) |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | D | 0.00 | 124,100 | 0 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | D | 13.34 | 140,000 | 1,867,600 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | D | 13.34 | 100,000 | 1,334,000 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | D | 4.31 | 6,913 | 29,781 | 0 | |
Sep 22 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Sell | D | 0.00 | 57,655 | 0 | 0 | 57.7 K to 0 (-100.00 %) |
Jun 30 2014 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 15.96 | 20,000 | 319,200 | 20,000 | |
Jun 30 2014 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 15.96 | 20,000 | 319,200 | 20,000 | |
Jun 30 2014 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 15.96 | 20,000 | 319,200 | 20,000 | |
Jun 30 2014 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 15.96 | 20,000 | 319,200 | 20,000 | |
Jun 30 2014 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP Finance | Option Exercise | A | 0.00 | 80,000 | 0 | 80,000 | |
Jun 30 2014 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP Finance | Option Exercise | A | 15.96 | 90,000 | 1,436,400 | 90,000 | |
May 21 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Sell | S | 12.94 | 12,939 | 167,431 | 88,555 | 101.5 K to 88.6 K (-12.75 %) |
May 21 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Sell | S | 12.94 | 9,361 | 121,131 | 93,235 | 102.6 K to 93.2 K (-9.12 %) |
May 21 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Sell | S | 12.94 | 10,159 | 131,457 | 44,552 | 54.7 K to 44.6 K (-18.57 %) |
May 21 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Sell | S | 12.94 | 31,742 | 410,741 | 148,930 | 180.7 K to 148.9 K (-17.57 %) |
Apr 17 2014 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 12.29 | 40,000 | 491,600 | 40,000 | |
Mar 07 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 0.00 | 124,100 | 0 | 124,100 | |
Mar 07 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 13.34 | 100,000 | 1,334,000 | 100,000 | |
Mar 07 2014 | HZNP | Horizon Pharma plc | Carey Robert | EVP & Chief Busines ... | Option Exercise | A | 13.34 | 140,000 | 1,867,600 | 140,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | A | 0.00 | 62,000 | 0 | 62,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | A | 7.61 | 70,000 | 532,700 | 70,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Option Exercise | A | 0.00 | 198,000 | 0 | 198,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Option Exercise | A | 7.61 | 223,000 | 1,697,030 | 223,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Option Exercise | A | 0.00 | 62,000 | 0 | 62,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Option Exercise | A | 7.61 | 70,000 | 532,700 | 70,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 62,000 | 0 | 62,000 | |
Jan 10 2014 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Option Exercise | A | 7.61 | 70,000 | 532,700 | 70,000 | |
Dec 17 2013 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Buy | P | 6.50 | 32,075 | 208,488 | 178,478 | 146.4 K to 178.5 K (+21.91 %) |
Dec 17 2013 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Buy | P | 6.50 | 636,598 | 4,137,887 | 2,837,826 | 2.2 M to 2.8 M (+28.92 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Option Exercise | M | 0.00 | 8,208 | 0 | 16,416 | |
Dec 09 2013 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Buy | M | 0.00 | 8,208 | 0 | 91,346 | 83.1 K to 91.3 K (+9.87 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Grant | A | 0.00 | 18,037 | 0 | 83,138 | 65.1 K to 83.1 K (+27.71 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Option Exercise | M | 0.00 | 3,350 | 0 | 6,698 | |
Dec 09 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Sell | S | 6.93 | 10,000 | 69,300 | 40,961 | 51 K to 41 K (-19.62 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Sell | S | 6.79 | 1,322 | 8,976 | 50,961 | 52.3 K to 51 K (-2.53 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Buy | M | 0.00 | 3,350 | 0 | 52,283 | 48.9 K to 52.3 K (+6.85 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Grant | A | 0.00 | 18,037 | 0 | 48,933 | 30.9 K to 48.9 K (+58.38 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | M | 0.00 | 8,208 | 0 | 16,416 | |
Dec 09 2013 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Buy | M | 0.00 | 8,208 | 0 | 90,244 | 82 K to 90.2 K (+10.01 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Grant | A | 0.00 | 21,640 | 0 | 82,036 | 60.4 K to 82 K (+35.83 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Option Exercise | M | 0.00 | 33,210 | 0 | 66,421 | |
Dec 09 2013 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Sell | S | 6.79 | 12,124 | 82,322 | 148,497 | 160.6 K to 148.5 K (-7.55 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Buy | M | 0.00 | 33,210 | 0 | 160,621 | 127.4 K to 160.6 K (+26.07 %) |
Dec 09 2013 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Grant | A | 0.00 | 43,290 | 0 | 127,411 | 84.1 K to 127.4 K (+51.46 %) |
Nov 25 2013 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Buy | P | 6.24 | 46,419 | 289,487 | 46,419 | 0 to 46.4 K |
Nov 25 2013 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Buy | P | 6.24 | 104,670 | 652,764 | 2,201,228 | 2.1 M to 2.2 M (+4.99 %) |
Jun 03 2013 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 2.37 | 20,000 | 47,400 | 20,000 | |
Jun 03 2013 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 2.37 | 20,000 | 47,400 | 20,000 | |
Jun 03 2013 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 2.37 | 20,000 | 47,400 | 20,000 | |
May 31 2013 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Option Exercise | A | 2.37 | 20,000 | 47,400 | 20,000 | |
Feb 22 2013 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 3.95 | 5,265 | 20,797 | 5,265 | |
Feb 22 2013 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 3.95 | 5,265 | 20,797 | 5,265 | |
Feb 22 2013 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 3.95 | 5,265 | 20,797 | 5,265 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Option Exercise | A | 0.00 | 55,000 | 0 | 55,000 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Option Exercise | A | 2.40 | 61,000 | 146,400 | 61,000 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Sell | S | 2.36 | 6,998 | 16,515 | 22,570 | 29.6 K to 22.6 K (-23.67 %) |
Jan 03 2013 | HZNP | Horizon Pharma plc | SMITH TODD N | EVP & Chief Commerc ... | Grant | A | 0.00 | 22,500 | 0 | 29,568 | 7.1 K to 29.6 K (+318.34 %) |
Jan 03 2013 | HZNP | Horizon Pharma plc | ADATTO MICHAEL | SVP, Managed Care & ... | Option Exercise | A | 0.00 | 19,800 | 0 | 19,800 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | ADATTO MICHAEL | SVP, Managed Care & ... | Option Exercise | A | 2.40 | 21,750 | 52,200 | 21,750 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | ADATTO MICHAEL | SVP, Managed Care & ... | Sell | S | 2.36 | 6,998 | 16,515 | 22,911 | 29.9 K to 22.9 K (-23.40 %) |
Jan 03 2013 | HZNP | Horizon Pharma plc | ADATTO MICHAEL | SVP, Managed Care & ... | Grant | A | 0.00 | 22,500 | 0 | 29,909 | 7.4 K to 29.9 K (+303.68 %) |
Jan 03 2013 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | A | 2.40 | 51,000 | 122,400 | 51,000 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Sell | S | 2.36 | 20,544 | 48,484 | 51,092 | 71.6 K to 51.1 K (-28.68 %) |
Jan 03 2013 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Option Exercise | A | 0.00 | 128,700 | 0 | 128,700 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Option Exercise | A | 2.40 | 147,000 | 352,800 | 147,000 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Sell | S | 2.36 | 20,749 | 48,968 | 78,661 | 99.4 K to 78.7 K (-20.87 %) |
Jan 03 2013 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Option Exercise | A | 2.40 | 51,000 | 122,400 | 51,000 | |
Jan 03 2013 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Buy | S | 2.36 | 16,304 | 38,477 | 55,099 | 38.8 K to 55.1 K (+42.03 %) |
Dec 12 2012 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Option Exercise | M | 0.00 | 8,208 | 0 | 24,624 | |
Dec 12 2012 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP & Chief Medical ... | Buy | M | 0.00 | 8,208 | 0 | 71,403 | 63.2 K to 71.4 K (+12.99 %) |
Dec 12 2012 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Option Exercise | M | 0.00 | 8,208 | 0 | 24,624 | |
Dec 12 2012 | HZNP | Horizon Pharma plc | DE VAERE ROBERT J | EVP & CFO | Buy | M | 0.00 | 8,208 | 0 | 71,636 | 63.4 K to 71.6 K (+12.94 %) |
Dec 12 2012 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Option Exercise | M | 0.00 | 33,211 | 0 | 99,631 | |
Dec 12 2012 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Sell | S | 2.28 | 10,301 | 23,486 | 99,410 | 109.7 K to 99.4 K (-9.39 %) |
Dec 12 2012 | HZNP | Horizon Pharma plc | Walbert Timothy P | President, Chairman ... | Buy | M | 0.00 | 33,211 | 0 | 109,711 | 76.5 K to 109.7 K (+43.41 %) |
Dec 12 2012 | HZNP | Horizon Pharma plc | ADATTO MICHAEL | SVP, Sales & Manage ... | Option Exercise | M | 0.00 | 3,349 | 0 | 10,048 | |
Dec 12 2012 | HZNP | Horizon Pharma plc | ADATTO MICHAEL | SVP, Sales & Manage ... | Buy | M | 0.00 | 3,349 | 0 | 7,409 | 4.1 K to 7.4 K (+82.49 %) |
Dec 12 2012 | HZNP | Horizon Pharma plc | SMITH TODD N | SVP, Marketing & Al ... | Option Exercise | M | 0.00 | 3,349 | 0 | 10,048 | |
Dec 12 2012 | HZNP | Horizon Pharma plc | SMITH TODD N | SVP, Marketing & Al ... | Buy | M | 0.00 | 3,349 | 0 | 7,068 | 3.7 K to 7.1 K (+90.05 %) |
Oct 10 2012 | HZNP | Horizon Pharma plc | Quaker BioVentures II LP | 10% Owner | Option Exercise | X | 0.01 | 546,198 | 5,462 | 0 | |
Oct 10 2012 | HZNP | Horizon Pharma plc | Quaker BioVentures II LP | 10% Owner | Buy | X | 0.01 | 546,198 | 5,462 | 3,516,009 | 3 M to 3.5 M (+18.39 %) |
Sep 27 2012 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Option Exercise | P | 4.57 | 14,578 | 66,621 | 14,578 | |
Sep 27 2012 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Option Exercise | P | 4.57 | 273,100 | 1,248,067 | 273,100 | |
Sep 27 2012 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Buy | P | 3.49 | 29,156 | 101,754 | 99,912 | 70.8 K to 99.9 K (+41.21 %) |
Sep 27 2012 | HZNP | Horizon Pharma plc | BIRD JEFFREY W | Director | Buy | P | 3.49 | 546,200 | 1,906,238 | 2,096,558 | 1.6 M to 2.1 M (+35.23 %) |